174 related articles for article (PubMed ID: 22172114)
1. [Role of the pathologist in the processing of adenocarcinoma of the stomach, oesophagogastric junction and lower third of the oesophagus].
Svrcek M; Fléjou JF
Ann Pathol; 2011 Dec; 31(6):419-26. PubMed ID: 22172114
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
[TBL] [Abstract][Full Text] [Related]
3. Individualized surgical strategies for cancer of the esophagogastric junction.
Stein HJ; Feith M; Siewert JR
Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
[TBL] [Abstract][Full Text] [Related]
4. Current trends in the surgical treatment of esophageal and cardia adenocarcinoma.
Peracchia A; Bonavina L; Via A; Incarbone R
J Exp Clin Cancer Res; 1999 Sep; 18(3):289-94. PubMed ID: 10606171
[TBL] [Abstract][Full Text] [Related]
5. [Neoadjuvant treatment of breast cancer: implications for the pathologist].
Le Guellec S; Perallon R; Alunni JP; Charitansky H; Leaha C; Gonzalez AM; Chateau MC; Simony-Lafontaine J; Jacot W; Gutowski M; Penault-Llorca F; Dalenc F; Lacroix-Triki M
Ann Pathol; 2011 Dec; 31(6):442-54. PubMed ID: 22172117
[TBL] [Abstract][Full Text] [Related]
6. Cancer of the gastroesophageal junction: combined modality therapy.
Ilson DH
Surg Oncol Clin N Am; 2006 Oct; 15(4):803-24. PubMed ID: 17030275
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of non-metastatic esophagogastric junction adenocarcinoma: what are the current options?
Gronnier C; Piessen G; Mariette C
J Visc Surg; 2012 Feb; 149(1):e23-33. PubMed ID: 22341763
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant radio-chemotherapy of adenocarcinoma of the oesophagogastric junction.
Samel S; Hofheinz R; Hundt A; Sturm J; Knoll MR; Wenz F; Queisser W; Post S
Onkologie; 2001 Jun; 24(3):278-82. PubMed ID: 11455222
[TBL] [Abstract][Full Text] [Related]
9. [Surgical treatment of carcinomas of the oesophagogastric junction - results achieved in multicentre studies].
Steinert R; Gastinger I; Ridwelski K; Ptok H; Wolff S; Meyer F; Otto R; Lippert H
Zentralbl Chir; 2013 Aug; 138(4):403-9. PubMed ID: 23950077
[TBL] [Abstract][Full Text] [Related]
10. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of oesophageal cancer.
Veuillez V; Rougier P; Seitz JF
Best Pract Res Clin Gastroenterol; 2007; 21(6):947-63. PubMed ID: 18070697
[TBL] [Abstract][Full Text] [Related]
11. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients.
Feith M; Stein HJ; Siewert JR
Surg Oncol Clin N Am; 2006 Oct; 15(4):751-64. PubMed ID: 17030271
[TBL] [Abstract][Full Text] [Related]
12. Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use?
Briasoulis E; Fatouros M; Roukos DH
Ann Surg Oncol; 2007 Oct; 14(10):2691-5. PubMed ID: 17653806
[No Abstract] [Full Text] [Related]
13. [Histological classification: evaluation of resection specimens of EMR/ESD--response evaluation after neoadjuvant therapy].
Munding J; Ziebarth W; Belyaev O; Uhl W; Tannapfel A
Zentralbl Chir; 2013 Dec; 138 Suppl 2():e55-62. PubMed ID: 22025359
[TBL] [Abstract][Full Text] [Related]
14. Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.
Lutz MP; Zalcberg JR; Ducreux M; Ajani JA; Allum W; Aust D; Bang YJ; Cascinu S; Hölscher A; Jankowski J; Jansen EP; Kisslich R; Lordick F; Mariette C; Moehler M; Oyama T; Roth A; Rueschoff J; Ruhstaller T; Seruca R; Stahl M; Sterzing F; van Cutsem E; van der Gaast A; van Lanschot J; Ychou M; Otto F;
Eur J Cancer; 2012 Nov; 48(16):2941-53. PubMed ID: 22921186
[TBL] [Abstract][Full Text] [Related]
15. Mucosal endocrine cell micronests and single endocrine cells following neo-adjuvant therapy for adenocarcinoma of the distal oesophagus and oesophagogastric junction.
Stewart CJ; Hillery S
J Clin Pathol; 2007 Nov; 60(11):1284-9. PubMed ID: 17893119
[TBL] [Abstract][Full Text] [Related]
16. [Preoperative neoadjuvant chemotherapy in esophago-cardial adenocarcinoma?].
Geissler M
Dtsch Med Wochenschr; 2006 Jun; 131(23):1344. PubMed ID: 16761207
[No Abstract] [Full Text] [Related]
17. Best practice in macroscopic examination of gastric resections.
Pritchard SA
J Clin Pathol; 2008 Feb; 61(2):172-8. PubMed ID: 17675536
[TBL] [Abstract][Full Text] [Related]
18. [Treatment procedures for adenocarcinoma of the esophagogastric junction].
Moesta KT; Hünerbein M; Schlag PM
Chirurg; 2003 Apr; 74(4):381-92; quiz 392-3. PubMed ID: 12719881
[No Abstract] [Full Text] [Related]
19. Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinoma.
Abbrederis K; Bassermann F; Schuhmacher C; Voelter V; Busch R; Roethling N; Sendler A; Siewert JR; Peschel C; Lordick F
Ann Thorac Surg; 2006 Jul; 82(1):293-7. PubMed ID: 16798232
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction.
Lagarde SM; ten Kate FJ; Reitsma JB; Busch OR; van Lanschot JJ
J Clin Oncol; 2006 Sep; 24(26):4347-55. PubMed ID: 16963732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
